ANALISIS PENGGUNAAN ASETOSAL DOSIS RENDAH TERHADAP PROSENTASE AGREGASI PLATELET PADA PASIEN KEHAMILAN RESIKO TINGGI HIPERTENSI (Penelitian dilakukan di Poli Hamil SMF Obstetri & Ginekologi Rumah Sakit Umum Haji dan Puskesmas Wonokromo Surabaya)
Low dose aspirin (LDA) is one of platelet aggregation agents in high risk pregnancy that is believed to prevent complication by inhibiting thromboxane A2 as a strong vasoconstrictor in platelet. It can inhibit platelet aggregation involved in pathophysiology of pregnancy hypertension. The aim of...
Saved in:
| Main Author: | |
|---|---|
| Format: | Theses and Dissertations NonPeerReviewed |
| Language: | Indonesian Indonesian |
| Published: |
2018
|
| Subjects: | |
| Online Access: | http://repository.unair.ac.id/77135/1/TFK.%2042-18%20Wip%20a%20Abstrak.pdf http://repository.unair.ac.id/77135/2/TFK.%2042-18%20Wip%20a.pdf http://repository.unair.ac.id/77135/ http://lib.unair.ac.id |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Universitas Airlangga |
| Language: | Indonesian Indonesian |
| Summary: | Low dose aspirin (LDA) is one of platelet aggregation agents in high risk pregnancy
that is believed to prevent complication by inhibiting thromboxane A2 as a strong
vasoconstrictor in platelet. It can inhibit platelet aggregation involved in pathophysiology of
pregnancy hypertension. The aim of this study was to analyze the effect of LDA on platelet
aggregation in pregnant patient with high risk hypertension.
A prospective observational method was conducted in this study. It was approved
by the Ethics Committee of Haji Teaching Hospital Surabaya. Data was collected from July
to September 2018 involving 18 patients divided into three groups who have age of 35-39
years old in majority. The range of gestational age in this study was 19-37 weeks. Platelet
aggregation on plasma were masured before and 14 days – 30 days after LDA use. The
collected data were statistically analyzed by using paired t-test.
The result showed that platelet aggregation percentage using collagen agonists was
an increase of 0.8% (p > 0.05) in the old patients group and followed by 6% (p > 0.05) in
the group of patients who did not get LDA. Whereas in the group of new patients showed a
decrease of 6% (p > 0.05). While ADP agonists showed that the group of new patients
decreased by 17% (p > 0.05), followed by the group of patients who did not use LDA of 9%
(p > 0.05) and the old patient group was 4% (p > 0.05).
It could be concluded that low-dose aspirin use did not affect a decrease in platelet
aggregation values. |
|---|